133 related articles for article (PubMed ID: 24623698)
1. A simple method for early age phenotype confirmation using toe tissue from a mouse model of MPS IIIA.
Trim PJ; Lau AA; Hopwood JJ; Snel MF
Rapid Commun Mass Spectrom; 2014 Apr; 28(8):933-8. PubMed ID: 24623698
[TBL] [Abstract][Full Text] [Related]
2. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
Zhang H; Wood T; Young SP; Millington DS
Mol Genet Metab; 2015 Feb; 114(2):123-8. PubMed ID: 25458519
[TBL] [Abstract][Full Text] [Related]
3. Synthetic Disaccharide Standards Enable Quantitative Analysis of Stored Heparan Sulfate in MPS IIIA Murine Brain Regions.
He QQ; Trim PJ; Lau AA; King BM; Hopwood JJ; Hemsley KM; Snel MF; Ferro V
ACS Chem Neurosci; 2019 Aug; 10(8):3847-3858. PubMed ID: 31264853
[TBL] [Abstract][Full Text] [Related]
4. A novel LC-MS/MS assay for heparan sulfate screening in the cerebrospinal fluid of mucopolysaccharidosis IIIA patients.
Naimy H; Powell KD; Moriarity JR; Wu J; McCauley TG; Haslett PA; Barbier AJ; Qiu Y
Bioanalysis; 2016 Feb; 8(4):285-95. PubMed ID: 26847798
[TBL] [Abstract][Full Text] [Related]
5. Robust LC-MS/MS methods for analysis of heparan sulfate levels in CSF and brain for application in studies of MPS IIIA.
Makower Å; Arnelöf E; Andersson T; Edlund PO; Gustavsson S; Janson J; Gelius SS; Tjernberg A
Bioanalysis; 2019 Aug; 11(15):1389-1403. PubMed ID: 31490106
[No Abstract] [Full Text] [Related]
6. Increased Alveolar Heparan Sulphate and Reduced Pulmonary Surfactant Amount and Function in the Mucopolysaccharidosis IIIA Mouse.
Paget TL; Parkinson-Lawrence EJ; Trim PJ; Autilio C; Panchal MH; Koster G; Echaide M; Snel MF; Postle AD; Morrison JL; Pérez-Gil J; Orgeig S
Cells; 2021 Apr; 10(4):. PubMed ID: 33918094
[TBL] [Abstract][Full Text] [Related]
7. Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III.
de Ruijter J; de Ru MH; Wagemans T; Ijlst L; Lund AM; Orchard PJ; Schaefer GB; Wijburg FA; van Vlies N
Mol Genet Metab; 2012 Dec; 107(4):705-10. PubMed ID: 23084433
[TBL] [Abstract][Full Text] [Related]
8. A modified liquid chromatography/tandem mass spectrometry method for predominant disaccharide units of urinary glycosaminoglycans in patients with mucopolysaccharidoses.
Chuang CK; Lin HY; Wang TJ; Tsai CC; Liu HL; Lin SP
Orphanet J Rare Dis; 2014 Sep; 9():135. PubMed ID: 25178307
[TBL] [Abstract][Full Text] [Related]
9. Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry.
Tomatsu S; Montaño AM; Oguma T; Dung VC; Oikawa H; Gutiérrez ML; Yamaguchi S; Suzuki Y; Fukushi M; Barrera LA; Kida K; Kubota M; Orii T
Mol Genet Metab; 2010 Feb; 99(2):124-31. PubMed ID: 19932038
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice.
Langford-Smith K; Arasaradnam M; Wraith JE; Wynn R; Bigger BW
Mol Genet Metab; 2010 Mar; 99(3):269-74. PubMed ID: 19926322
[TBL] [Abstract][Full Text] [Related]
11. Exocytosis is impaired in mucopolysaccharidosis IIIA mouse chromaffin cells.
Keating DJ; Winter MA; Hemsley KM; Mackenzie KD; Teo EH; Hopwood JJ; Brooks DA; Parkinson-Lawrence EJ
Neuroscience; 2012 Dec; 227():110-8. PubMed ID: 23022219
[TBL] [Abstract][Full Text] [Related]
12. Low-dose, continuous enzyme replacement therapy ameliorates brain pathology in the neurodegenerative lysosomal disorder mucopolysaccharidosis type IIIA.
King B; Hassiotis S; Rozaklis T; Beard H; Trim PJ; Snel MF; Hopwood JJ; Hemsley KM
J Neurochem; 2016 May; 137(3):409-22. PubMed ID: 26762778
[TBL] [Abstract][Full Text] [Related]
13. Lentiviral-mediated gene therapy for murine mucopolysaccharidosis type IIIA.
McIntyre C; Derrick Roberts AL; Ranieri E; Clements PR; Byers S; Anson DS
Mol Genet Metab; 2008 Apr; 93(4):411-8. PubMed ID: 18248829
[TBL] [Abstract][Full Text] [Related]
14. Glycosaminoglycan levels and structure in a mucopolysaccharidosis IIIA mice and the effect of a highly secreted sulfamidase engineered to cross the blood-brain barrier.
Maccari F; Sorrentino NC; Mantovani V; Galeotti F; Fraldi A; Volpi N
Metab Brain Dis; 2017 Feb; 32(1):203-210. PubMed ID: 27585464
[TBL] [Abstract][Full Text] [Related]
15. Examination of intravenous and intra-CSF protein delivery for treatment of neurological disease.
Hemsley KM; Luck AJ; Crawley AC; Hassiotis S; Beard H; King B; Rozek T; Rozaklis T; Fuller M; Hopwood JJ
Eur J Neurosci; 2009 Mar; 29(6):1197-214. PubMed ID: 19302155
[TBL] [Abstract][Full Text] [Related]
16. Effect of high dose, repeated intra-cerebrospinal fluid injection of sulphamidase on neuropathology in mucopolysaccharidosis type IIIA mice.
Mader KM; Beard H; King BM; Hopwood JJ
Genes Brain Behav; 2008 Oct; 7(7):740-53. PubMed ID: 18518922
[TBL] [Abstract][Full Text] [Related]
17. Accelerated clinical disease and pathology in mucopolysaccharidosis type IIIB and GalNAc transferase double knockout mice.
Mohammed EE; Snella EM; Rutz-Mendicino MM; Echevarria FD; Awedikian R; Whitley EM; Ellinwood NM
Mol Genet Metab; 2012 Sep; 107(1-2):129-35. PubMed ID: 22867887
[TBL] [Abstract][Full Text] [Related]
18. Analytical method for the determination of disaccharides derived from keratan, heparan, and dermatan sulfates in human serum and plasma by high-performance liquid chromatography/turbo ionspray ionization tandem mass spectrometry.
Oguma T; Tomatsu S; Montano AM; Okazaki O
Anal Biochem; 2007 Sep; 368(1):79-86. PubMed ID: 17603992
[TBL] [Abstract][Full Text] [Related]
19. Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry.
Kubaski F; Mason RW; Nakatomi A; Shintaku H; Xie L; van Vlies NN; Church H; Giugliani R; Kobayashi H; Yamaguchi S; Suzuki Y; Orii T; Fukao T; Montaño AM; Tomatsu S
J Inherit Metab Dis; 2017 Jan; 40(1):151-158. PubMed ID: 27718145
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications.
Yogalingam G; Hopwood JJ
Hum Mutat; 2001 Oct; 18(4):264-81. PubMed ID: 11668611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
